CNTO 328
Drug timelines are a Plus or Pro feature.
7 regulatory and trial events tracked for CNTO 328, covering 2013-02-20 to 2015-08-04. Get the full timeline:
Most recent: Clinical Trial Update: A Study of the Safety and Efficacy of CNTO 328 and Bortezomib to Bortezomib Alone in Patients With Relapsed or Refractory Multiple Myeloma [Phase 2]